Researchers have identified a small molecule, named as SHP656, that can target the brain’s clock proteins and may prove effective for treating glioblastoma.
Peer-influenced content. Sources you trust. No registration required. This is HCN.
Researchers have identified a small molecule, named as SHP656, that can target the brain’s clock proteins and may prove effective for treating glioblastoma.